Session Information

  • WCLC 2020

    2020 World Conference on Lung Cancer

    Conference Program for the 2020 World Conference on Lung Cancer in Singapore


    Presentation Date(s):  
    • January 28 - 31, 2021
    • Total Presentations: 1597

    All times listed are in Singapore time (GMT+8)

    PL - Plenary
    PS - Presidential Symposium
    ES - Education Session
    OA - Oral Session
    MA - Mini Oral Session
    FP - Featured Posters
    P - Posters
    IS - Industry Symposium
    JICC - Joint IASLC-CAALC-CSCO Session

Filter Results:

Show Only CME Accredited Sessions

  • +

    FP07 - Pathology

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Type: Posters (Featured)
    • Track: Pathology, Molecular Pathology and Diagnostic Biomarkers
    • +

      FP07.06 - Lung Immune Prognostic Index (LIPI) in Advanced NSCLC Patients Treated with Immunotherapy, Chemotherapy and both Combined Upfront.

      00:00 - 00:00  |  Presenter: Laura Mezquita

      • Abstract

      Loading...

  • +

    P18 - Locoregional and Oligometastatic Disease - Misc. Topics

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Locoregional and Oligometastatic Disease
    • +

      P18.05 - Immunotherapy Beyond First-Line in NSCLC, Still An Option.

      00:00 - 00:00  |  Presenter: Andrea Modrego

      • Abstract

      Loading...

  • +

    P21 - Locoregional and Oligometastatic Disease - Treatment of Locally Advanced NSCLC

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Locoregional and Oligometastatic Disease
    • +

      P21.14 - The Promising role of Chemo-Immunotherapy in Non-Small Cell Lung Cancer Neoadjuvant Setting

      00:00 - 00:00  |  Presenter: Helena Bote

      • Abstract

      Loading...

  • +

    OA11 - A Symphony of Progress

    • 15:30 - 16:30
    • 1/31/2021
    • Location: Scientific Program Auditorium
    • IASLC CME Accredited
    • Type: Oral
    • Track: Small Cell Lung Cancer/NET
    • +

      OA11.04 - Lurbinectedin With Irinotecan in Relapsed Small Cell Lung Cancer. Results From the Expansion Stage of a Phase I-II Trial

      15:40 - 15:50  |  Presenter: Santiago Ponce-Aix

      • Abstract

      Loading...